Twenty-one years after its approval by the FDA, mifepristone could—but probably won’t— revolutionize a post-Roe world. By Cynthia Koons

The $10 Billion Startup Training AI to Replace the White-Collar Workforce
29:54

‘God, It’s Terrifying’: How the Pentagon Got Hooked on AI War Machines
21:14

How a Die-Hard Libertarian Is Negotiating Lower Health-Care Costs
22:36